Pre- and postsynaptic serotoninergic excitation of globus pallidus neurons

Journal of Neurophysiology

Volumn 100, Issue 2, 2008, Pages 1053-1066

  Rav Acha, Moshe ^a   Bergman, Hagai ^a   Yarom, Yosef ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CATION CHANNEL; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN ANTAGONIST; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; PYRIDAZINE DERIVATIVE; SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; EVOKED RESPONSE; GLOBUS PALLIDUS; HYPERPOLARIZATION; INTRACELLULAR RECORDING; NERVE CELL EXCITABILITY; NONHUMAN; OSCILLATION; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; VOLTAGE CLAMP; ANIMAL; CELL MEMBRANE POTENTIAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; IN VITRO STUDY; METABOLISM; METHODOLOGY; NERVE CELL; NEWBORN; PATCH CLAMP; PHYSIOLOGY; RADIATION RESPONSE; RAT; SYNAPSE; SYNAPTOSOME;

ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PRESYNAPTIC TERMINALS; PYRIDAZINES; RATS; SEROTONIN; SEROTONIN AGENTS; SYNAPSES;

EID: 55249103354     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00845.2007     Document Type: Article

References (69)

1. Abbott LF, Varela JA, Sen K, Nelson SB. Synaptic depression and cortical gain control. Science 275: 220-224, 1997.
2. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375, 1989.
3. Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB. Autoradiographic characterization of (±)-1-(2,5-dimethoxy-4- [125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. J Pharmacol Exp Ther 255: 843-857, 1990.
4. Bara-Jimenez W, Bibbiani F, Morris MJ, Dimitrova T, Sherzai A, Mouradian MM, Chase TN. Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease. Mov Disord 20: 932-936, 2005.
5. Bergman H, Feingold A, Nini A, Raz A, Slovin H, Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and Parkinsonian primates. Trends Neurosci 21: 32-38, 1998.
6. Bergstrom DA, Walters JR. Neuronal responses of the globus pallidus to systemic administration of d-amphetamine: investigation of the involvement of dopamine, norepinephrine, and serotonin. J Neurosci 1: 292-299, 1981.
7. Bickmeyer U, Heine M, Manzke T, Richter DW. Differential modulation of I(h) by 5-HT receptors in mouse CA1 hippocampal neurons. Eur J Neurosci 16: 209-218, 2002.
8. Bonaventure P, Nepomuceno D, Kwok A, Chai W, Langlois X, Hen R, Stark K, Carruthers N, Lovenberg TW. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. Pharmacol Exp Ther 302: 240-248, 2002.
9. Bonuccelli U, Del Dotto P. New pharmacologic horizons in the treatment of Parkinson disease. Neurology 67, Suppl. 5: S30-S38, 2006.
10. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 247, Suppl. 2: 3-10, 2000.
11. Brotchie JM. Nondopaminergic mechanisms in levodopa-induced dyskinesia. Mov Disord 20: 919-931, 2005.
12. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 18: 357-363, 2003.
13. Brown P. Bad oscillations in Parkinson's disease. J Neural Transm 70: 27-30, 2006.
14. Caley CF. Extrapyramidal reactions and the selective serotonin reuptake inhibitors. Ann Pharmacother 31: 1481-1489, 1997.
15. Cardenas CG, Mar LP, Arnold PB, Cardenas LM, Surmeier DJ, Scroggs RS. Serotoninergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 518: 507-523, 1999.
16. Chadha A, Sur C, Atack J, Duty S. The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br J Pharmacol 130: 1927-1932, 2000.
17. Chan CS, Shigemoto R, Mercer JN, Surmeier DJ. HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons. J Neurosci 24: 9921-9932, 2004.
18. Chen L, Yung KKL, Chan YS, Yung WH. 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience 151: 439-451, 2008.
19. Compan V, Daszuta A, Salin P, Sebben M, Bockaert J, Dumuis A. Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. Eur J Neurosci 8: 2591-2598, 1996.
20. Compan V, Segu L, Buhot MC, Daszuta A. Selective increases in serotonin 5-HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. Brain Res 793: 103-111, 1998.
21. DeLong MR. Activity of pallidal neurons during movement. J Neurophysiol 34: 414-427, 1971.
22. Di Cara B, Samuel D, Salin P, Daszuta A. Serotoninergic regulation of the GABAergic transmission in rat basal ganglia. Synapse 50: 144-150, 2003.
23. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384: 233-247, 1997.
24. Gony M, Lapeyre-Mestre M, Montastruc JL. Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Clin Neuropharmacol 26: 142-145, 2003.
25. Halliday GM, Blumbergs PC, Cotoon RG, Blessing WW, Gerfin LB. Loss of brain stem serotonin and substance P-containing neurons in Parkinson's disease. Brain Res 510: 104-107, 1990.
26. Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 30: 357-364, 2007.
27. Hikosaka O. GABAergic output of the basal ganaglia. Prog Brain Res 160: 209-226, 2007.
28. Iwahori Y, Ikegaya Y, Matsuki N. Hyperpolarization-activated current I-h in nucleus solitary tract neurons: regional difference in serotoninergic modulation. Jpn J Pharmacol 88: 459-462, 2002.
29. Jiang ZG, Teshima K, Yang Y, Yoshioka T, Allen CN. Pre- and postsynaptic actions of serotonin on rat suprachiasmatic nucleus neurons. Brain Res 866: 247-256, 2000.
30. A synaptic potential in rat dopamine neurons. J Neurosci 12: 2000-2006, 1992.
31. B receptors in rat globus pallidus. J Neurophysiol 994: 1104-1114, 2005.
32. Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Verge D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol 365: 289-305, 1996.
33. Kita H. Responses of globus pallidus neurons to cortical stimulation: intracellular study in the rat. Brain Res 589: 84-90, 1992.
34. Kita H. Globus pallidus external segment. Prog Brain Res 160: 111-133, 2007.
35. B receptor-mediated responses of globus pallidus induced after stimulation of the putamen in the monkey. J Neurosci 26: 6554-6562, 2005.
36. Kita H, Chiken S, Tachibana Y, Nambu A. Serotonin modulates pallidal neuronal activity in the awake monkey. J Neurosci 27: 75-83, 2007.
37. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3: 309-316, 2004.
38. Liu Z, Bunney EB, Appel SB, Brodie MS. Serotonin reduces the hyperpolarization-activated current (Ih) in ventral tegmental area dopamine neurons: involvement of 5-HT2 receptors and protein kinase C. J Neurophysiol 90: 3201-3212, 2003.
39. Long MA, Landisman CE, Connors BW. Small clusters of electrically coupled neurons generate synchronous rhythms in the thalamic reticular nucleus. J Neurosci 24: 341-349, 2004.
40. Mengod G, Nguyen H, Le H, Waeber C, Lubbert H, Palacios JM. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35: 577-591, 1990.
41. Mengod G, Pompeiano M, Martinez-Mir MI, Palacios JM. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524: 139-143, 1990.
42. Mignon L, Wolf WA. Postsynaptic 5-HT(1A) receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease. Psychopharmacology (Berl) 192: 49-59, 2007.
43. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50: 381-425, 1996.
44. Nambu A, Llinás R. Electrophysiology of globus pallidus neurons in vitro. J Neurophysiol 72: 1127-1139, 1994.
45. Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M. Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21: 63-73, 2001.
46. Nicholson SL, Brotchie JM. 5-Hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy. Eur J Neurol 9, Suppl. 3: 1-6, 2002.
47. Nini A, Feingold A, Slovin H, Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 74: 1800-1805, 1995.
48. Obeso JA, Rodriguez-Oroz MC, Rodriguez M. Pathophysiology of the basal ganglia in Parkinson's disease. Trend Neurosci 23: s8-s19, 2000.
49. O'Donovan MJ, Rinzel J. Synaptic depression: a dynamic regulator of synaptic communication with varied functional roles. Trends Neurosci 20: 431-433, 1997.
50. Pape HC. Queer current and pacemaker: the hyperpolarization activated cation current in neurons. Ann Rev Physiol 58: 299-327, 1996.
51. 35-HT. Neuroscience 6: 115-138, 1981.
52. Pazos A, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205-230, 1985.
53. Perkins MN, Stone TW. Neuronal responses to 5-hydroxytryptamine and dorsal raphe stimulation within the globus pallidus of the rat. Exp Neurol 79: 118-129, 1983.
54. Querejeta E, Oviedo-Chávez A, Araujo-Alvarez JM, Quiñones-Cárdenas AR, Delgado A. In vivo effects of local activation and blockade of 5-HT1B receptors on globus pallidus neuronal spiking. Brain Res 1043: 186-194, 2005.
55. Rav-Acha M, Sagiv N, Segev I, Bergman H, Yarom Y. Dynamic and spatial features of the inhibitory pallidal GABAergic synapses. Neuroscience 135: 791-802, 2005.
56. Rivlin-Etzion M, Marmor O, Heimer G, Raz A, Nini A, Bergman H. Basal ganglia oscillations and pathophysiology of movement disorders. Curr Opin Neurobiol 16: 629-637, 2006.
57. Sari Y. Serotonin 1B receptors: from protein to physiological function and behavior. Neurosci Behav Rev 28: 565-582, 2004.
58. 1B receptors in the rat central nervous system: immunohistochemical autoradiographic and lesion studies. Neuroscience 88: 899-915, 1999.
59. Schwartz R, Coyle JT. Striatal lesions with kianic acid: neurochemical characteristics. Brain Res 127: 235-249, 1977.
60. A IPSCs in the rat globus pallidus in vitro. J Neurosci 19: 4796-4803, 1999.
61. 2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci 16: 7566-7573, 1996.
62. Steinbusch HW. Distribution of serotonin-immunoreactivity in central nervous system of rat cell bodies and terminals. Neuroscience 6: 557-618, 1981.
63. To ZP, Bonhaus DW, Eglen RM, Jakeman LB. Characterization and distribution of putative 5-HT7 receptors in guinea-pig brain. Br J Pharmacol 115: 107-116, 1995.
64. Verge D, Calas A. Serotoninergic neurons and serotonin receptors: gains from cytochemical approaches. J Chem Neuroanat 18: 41-56, 2000.
65. Vilaro MT, Cortes R, Mengod G. Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol 484: 418-439, 2005.
66. Villalobos C, Beique JC, Andrade R. Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex. Eur J Neurosci 22: 1120-1126, 2005.
67. Waeber C, Moskowitz MA. Autoradiographic visualization of [3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain. Eur J Pharmacol 283: 31-46, 1995.
68. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 6: 751-758, 1996.
69. Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351: 357-373, 1995.